Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes

The molecular differences between postpartum (PPBC) and nulliparous (NPBC) young women breast cancer (YWBC) patients remain unknown. Here the authors perform RNA sequencing and multiplex immunohistochemistry on an FFPE breast cancer cohort and suggest that PPBC is a unique entity within YWBC with po...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sonali Jindal, Nathan D. Pennock, Duanchen Sun, Wesley Horton, Michelle K. Ozaki, Jayasri Narasimhan, Alexandra Q. Bartlett, Sheila Weinmann, Paul E. Goss, Virginia F. Borges, Zheng Xia, Pepper Schedin
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/0e10b40c44fd4f99a9a9f2ec3a3bf0dd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0e10b40c44fd4f99a9a9f2ec3a3bf0dd
record_format	dspace
spelling	oai:doaj.org-article:0e10b40c44fd4f99a9a9f2ec3a3bf0dd2021-11-08T11:05:32ZPostpartum breast cancer has a distinct molecular profile that predicts poor outcomes10.1038/s41467-021-26505-32041-1723https://doaj.org/article/0e10b40c44fd4f99a9a9f2ec3a3bf0dd2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-26505-3https://doaj.org/toc/2041-1723The molecular differences between postpartum (PPBC) and nulliparous (NPBC) young women breast cancer (YWBC) patients remain unknown. Here the authors perform RNA sequencing and multiplex immunohistochemistry on an FFPE breast cancer cohort and suggest that PPBC is a unique entity within YWBC with poor prognosis.Sonali JindalNathan D. PennockDuanchen SunWesley HortonMichelle K. OzakiJayasri NarasimhanAlexandra Q. BartlettSheila WeinmannPaul E. GossVirginia F. BorgesZheng XiaPepper SchedinNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Sonali Jindal Nathan D. Pennock Duanchen Sun Wesley Horton Michelle K. Ozaki Jayasri Narasimhan Alexandra Q. Bartlett Sheila Weinmann Paul E. Goss Virginia F. Borges Zheng Xia Pepper Schedin Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
description	The molecular differences between postpartum (PPBC) and nulliparous (NPBC) young women breast cancer (YWBC) patients remain unknown. Here the authors perform RNA sequencing and multiplex immunohistochemistry on an FFPE breast cancer cohort and suggest that PPBC is a unique entity within YWBC with poor prognosis.
format	article
author	Sonali Jindal Nathan D. Pennock Duanchen Sun Wesley Horton Michelle K. Ozaki Jayasri Narasimhan Alexandra Q. Bartlett Sheila Weinmann Paul E. Goss Virginia F. Borges Zheng Xia Pepper Schedin
author_facet	Sonali Jindal Nathan D. Pennock Duanchen Sun Wesley Horton Michelle K. Ozaki Jayasri Narasimhan Alexandra Q. Bartlett Sheila Weinmann Paul E. Goss Virginia F. Borges Zheng Xia Pepper Schedin
author_sort	Sonali Jindal
title	Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
title_short	Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
title_full	Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
title_fullStr	Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
title_full_unstemmed	Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
title_sort	postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/0e10b40c44fd4f99a9a9f2ec3a3bf0dd
work_keys_str_mv	AT sonalijindal postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT nathandpennock postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT duanchensun postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT wesleyhorton postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT michellekozaki postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT jayasrinarasimhan postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT alexandraqbartlett postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT sheilaweinmann postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT paulegoss postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT virginiafborges postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT zhengxia postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes AT pepperschedin postpartumbreastcancerhasadistinctmolecularprofilethatpredictspooroutcomes
_version_	1718442306437120000

Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes

Ejemplares similares